Iron deficiency (ID) affects 9%-16% of US women with well-documented morbidity in academic performance, mood, and concentration. Current ID screening depends on the detection of low hemoglobin (ie, anemia, ,12.0 g/dL). However, anemia is a late-stage indicator of ID. The study hypothesis was that using higher hemoglobin thresholds would optimize ID screening. The objective was to assess the sensitivity and specificity of hemoglobin to detect ID among nonpregnant, reproductive-age women of 12-49 years and to determine if psychometric characteristics varied by age and race. This cross-sectional study used National Health and Nutrition Examination Survey 2003-2010 data. ID was defined as body iron, calculated using ferritin and transferrin receptors. Logistic regression and receiver operating characteristic (ROC) curves were used to model the predictive probability of ID by hemoglobin values. ID prevalence by body iron was 11.5% (n 5 6602). Using ,12.0 g/dL, hemoglobin had a sensitivity of 42.9% (95% confidence interval [CI] 5 39.4%, 46.4%) and specificity of 95.5% (95% CI 5 95.0%, 96.0%) for ID. The ROC curve was optimized at the hemoglobin threshold of ,12.8 g/dL with the sensitivity and specificity of 71.3% (95% CI 5 68.0%, 74.5%) and 79.3% (95% CI 5 78.2%, 80.3%), respectively. The probability of ID at this threshold was 13.5% (95% CI 5 11.3%, 15.9%). Hemoglobin better predicted ID among older (22-49 years) vs younger (12-21 years) women (c-index 0.87 vs 0.77, P , 0.001). Among nonpregnant, reproductive-age women, current hemoglobin thresholds are insufficient to exclude ID. A threshold of ,12.8 g/dL improves the detection of ID. (Translational Research 2017;180:68-76) 
INTRODUCTION I
ron deficiency (ID) is the most common form of nutritional deficiency in the United States. 1, 2 Although ID affects all age groups, reproductiveage women are at higher risk secondary to increased iron demands from menstrual blood loss and pregnancy. It is estimated that 9%-16% of reproductive-age US women are iron deficient, whereas 2%-5% are anemic. 1, 3, 4 Anemia is a late-stage indicator of ID. To develop anemia, iron-deficient individuals must have significantly depleted the body's iron stores. 1 However, even nonanemic iron-deficient women have been shown to experience significant morbidity including poor academic performance, mood lability, and concentration difficulty, which is improved with iron supplementation. [5] [6] [7] [8] [9] [10] Recognizing the importance of detecting ID, the Centers for Disease Control and Prevention recommends testing all nonpregnant women for ID anemia ''every 5-10 years throughout their childbearing years during routine health examinations.'' 1, 2 Because of the lack of a single, simple, and inexpensive test for ID, screening is based on the detection of anemia with hemoglobin levels, which continues as a routine practice despite low sensitivity and specificity for detection of ID. 1, 2, 11, 12 Hemoglobin is a protein within red blood cells responsible for the delivery of oxygen to body tissues. 13 The hemoglobin protein itself contains iron, and the hemoglobin level is thus a reflection of the amount of functional iron in the body. Changes in hemoglobin levels only occur in the late stages of ID, making a decline in hemoglobin to anemic ranges, a late indicator of ID. 1 Although ID is perhaps the most common etiology of anemia among US women, anemia has many causes, and hemoglobin norms for detecting anemia were not designed solely to optimize the detection of ID. 10 In clinical practice, higher hemoglobin concentrations, aside from polycythemia, are often equated with better iron status. Yet, the diagnostic accuracy of using hemoglobin as a screening tool for ID is rarely discussed despite its routine use.
The objective of this study was to determine the optimal hemoglobin threshold that maximizes the sensitivity and specificity for detecting ID among nonpregnant, reproductive-age women of 12-49 years using National Health and Nutrition Examination Survey (NHANES) 2003-2010 data. As normal hemoglobin values vary by age, adolescent/young adult (12-21 years) and older (22-49 years) reproductive-age women were analyzed separately. 1, 2 It is anticipated that this information may enhance the value of hemoglobin testing for ID in clinical care and guide the decision to pursue additional iron studies.
MATERIALS AND METHODS
Study participants. The NHANES is a cross-sectional program of periodic surveys to assess the health and nutritional status of the US population.
14 The nationally representative surveys combine household interviews and physical examinations conducted in mobile examination centers by the National Center for Health Statistics, Centers for Disease Control and Prevention. The NHANES interview includes demographic, socioeconomic, dietary, and healthrelated questions. Participants are selected via a stratified multistage probability with oversamplings of certain groups (eg, African Americans and Hispanics) to produce reliable statistics. 14 The project was given a ''not human research'' determination by the Penn State College of Medicine Institutional Review Board.
This study included all women aged 12-49 years with hemoglobin, ferritin, and soluble transferrin receptor laboratory values recorded in NHANES 2003-2010. Because of variations in hemoglobin by age, younger (12-21 years) and older (22-49 years) women were examined separately. 1, 2 As hemoglobin values also vary by race, Black and non-Black women were examined separately. 15 Participants were excluded for a history of blood transfusion, as this suggests their ID may have causes (eg, trauma and malignancy) other than the ID most commonly managed in preventive care. 10 Pregnant or breastfeeding participants were also excluded. Finally, those with cancer, malignancy, and chronic kidney or liver disease were excluded, but these questions were only asked for participants older than 20 years. As acute and chronic infection or inflammation may influence the iron indices, consistent with Cogswell et al, 4 we also excluded participants with a white blood cell count . 
Background
Current iron deficiency (ID) screening depends on the detection of low hemoglobin (ie, anemia ,12.0 g/dL). However, as anemia is a late-stage indicator of ID, this strategy fails to identify most iron-deficient, reproductive-age women.
Translational Significance
Using National Health and Nutrition Examination Survey 2003-2010 data, logistic regression and receiver operating characteristic curves modeled the predictive probability of ID by hemoglobin. Using a hemoglobin threshold of ,12.8 g/dL optimized the sensitivity and specificity for ID. When screening reproductive-age women for ID, a higher hemoglobin threshold may better inform clinical decision-making regarding further iron studies.
body. 1 The normal hemoglobin range varies based on sex and age. For women aged 12-14 years, anemia is defined as a hemoglobin concentration ,11.8 g/dL. For women aged 15-49 years, anemia is defined as a hemoglobin concentration ,12.0 g/dL.
1,2 For selfidentified Black women, threshold for anemia diagnosis is 1 g/dL lower as recommended by the International Nutritional Anemia Consultative Group and the World Health Organization. 15 Parameters for the complete blood count, which includes the hemoglobin level, were based on the Beckman Coulter method of counting and sizing. This was performed in combination with an automatic diluting and mixing device for sample processing and a singlebeam photometer for hemoglobin measurement. 16 ID was calculated using the body iron formula developed by Cook et al. 4, 17 The formula requires laboratory values for ferritin and soluble transferrin receptors, which were included in the NHANES data set from 2003 to 2010. A negative value (,0 mg/kg) is indicative of ID. 4 However, as ferritin is more commonly used in clinical care than the body iron calculation to assess iron stores, a second analysis defining ID as ferritin ,12 mg/L was also conducted.
Two methods were used to measure ferritin in 2003 18 Before the release of the 2003 data, piecewise linear regression equations were applied to adjust the 2003 ferritin data to be comparable to the 2004 ferritin data. 18 The Roche/ Hitachi 912 nephelometric immunoassay was used in [2005] [2006] [2007] [2008] . 19, 20 In 2009-2010, the Roche Elecsys sandwich immunoassay was used. 21 The Roche/Hitachi ferritin assay had previously been compared with the Cook ferritin in the calculation of body iron with no differences found between the 2 methods. 4 Thus, the 2009-2010 ferritin measurements obtained using the Roche Elecsys 170 method were converted to the Roche/Hitachi 912 scale using the following equation: Hitachi 5 10 ([log 10(Elecsys) 2 0.049]/0.989) .
21
Soluble transferrin receptor was measured by immunoturbidimetry using Roche kits on the Hitachi 912 clinical analyzer from 2003 to 2008. [22] [23] [24] In 2009-2010, the Roche Hitachi Mod P immunoturbidimetric method was used. A crossover study was performed between the 2 methods, but no adjustment of the data was needed. 25 As per Cogswell et al, 4 the Roche soluble transferrin receptor values were converted to the equivalent in the Flowers assay used in developing the body iron model.
Statistical analyses. Because NHANES is a complex probability sample, the selected data were weighted appropriately as per the NHANES study guidelines to be representative of the current US population for all analyses. 26 All statistical analyses were performed using SAS software, version 9.4 (SAS Institute Inc, Cary). In particular, the procedure SURVEYLOGISTIC, which is specifically designed for complex survey analysis, was used to take into account the sampling weights and the complex study design to calculate proper variances of estimates.
Logistic regression was used to fit models assessing the association between hemoglobin and ID. From the logistic regression models, the predicted probability of ID and receiver operating characteristic (ROC) curves were generated. 27 The ROC curve is created by varying the diagnostic threshold of hemoglobin. The diagnostic threshold indicative of ID susceptibility for hemoglobin was selected based on the Youden index, which is defined by the following formula: sensitivity 1 specificity 2 1. The maximal Youden index identifies the optimal threshold when sensitivity and specificity are considered of equal importance, and this maximal value is the ''knee'' of the ROC curve. 28 The concordance index (c-index), also referred to as the area under the curve (AUC), is reported for the ROC curves. The c-index, a measure of predictive ability, is the proportion of all pairs of females with different outcomes (ID vs no ID) in which the females with the higher predicted probability of ID were indeed the females who had ID. A c-index value of 0.50 indicates completely random predictions, whereas a value of 1 indicates perfect predictions. For the c-index, Hosmer and Lemeshow 29 refer to ''acceptable discrimination'' if 0.7 # c-index , 0.8 and ''excellent discrimination'' if 0.8 # c-index , 0.9. Areas under the ROC curves were compared between the younger and older female groups using a chi-square test. (Table I) .
The ROC curve for all reproductive-age women had an AUC of 0.83 (95% confidence interval [CI] 5 0.82, 0.85; Fig 2, A) . From the ROC curve, as the hemoglobin threshold increases the sensitivity increases; however, the specificity declines. The ROC curve indicates that using values ,12.0 g/dL for ''abnormal'' hemoglobin (as is the recommended threshold for women aged 15-49 years) had a sensitivity of 42.9% (95% CI 5 39.4%, 46.4%) and a specificity of 95.5% (95% CI 5 95.0%, 96.0%) for ID. The ROC curve was optimized at a hemoglobin threshold of ,12.8 g/dL with the sensitivity and specificity for detection of ID of 71.3% (95% CI 5 68.0%, 74.5%) and 79.3% (95% CI 5 78.2%, 80.3%), respectively. The probability of having ID at this threshold was 13.5% (95% CI 5 11.3%, 15.9%; Fig 2, B) .
Age-stratified analyses. The analyses were then stratified by age, young women 12-21 years and older women 22-49 years. The ROC curve for women aged 12-21 years had an AUC of 0.77 (95% CI 5 0.74, 0.80; Fig 3, A) . A value of 11.8 g/dL is commonly used as the diagnostic threshold for normal hemoglobin in women aged 12-14 years, so this was examined on the ROC curve. Using a threshold of ,11.8 g/dL yields a sensitivity of 27.8% (95% CI 5 22.9%, 32.7%) and a specificity of 97.1% (95% CI 5 96.5%, 97.7%) among those aged 12-21 years. Using a threshold of ,12.0 g/dL yields a sensitivity of 34.7% (95% CI 5 29.5%, 39.9%) and a specificity of 95.0% (95% CI 5 94.2%, 95.9%). The ROC curve was optimized at a hemoglobin threshold of ,12.8 g/ dL with the sensitivity and specificity of 64.4 (95% CI 5 59.1%, 69.6%) and 77.4% (95% CI 5 75.8%, 79.0%), respectively. The probability of having ID at this threshold was 13.0% (95% CI 5 10.7%, 15.8%; Fig 3, B) . The ROC curve for older women aged 22-49 years had an AUC of 0.87 (95% CI 5 0.86, 0.89; Fig 4, A) . For older women, a hemoglobin threshold ,12.0 g/dL resulted in a sensitivity of 48.9% (95% CI 5 44.2%, 53.5%) and a specificity of 95.9% (95% CI 5 95.2%, 96.6%). The ROC curve was optimized at a hemoglobin threshold of ,12.7 g/dL with the sensitivity and specificity of 74.0% (95% CI 5 69.9%, 78.1%) and 83.5% (95% CI 5 82.2%, 84.8%), respectively. The probability of having ID at this threshold was 15.4% (95% CI 5 12.6%, 18.7%; Fig 4, B) . Furthermore, the AUC of 0.87 in the older women was significantly larger than the AUC of 0.77 observed for the younger women (P , 0.001).
Race-stratified analysis. ROC curves were similarly generated for Black and non-Black women. Using a threshold of ,11.0 g/dL (1 g/dL lower as stated previously 15 use of body iron (Table II) . The overall prevalence of ID when defined by ferritin ,12 mg/L was 14.0%. For all women aged 12-49 years, the ROC curve was optimized at a hemoglobin threshold of ,12.8 g/dL with a sensitivity of 63.9% (95% CI 5 60.8%, 67.0%) and a specificity of 79.5% (95% CI 5 78.5%, 80.6%). For young women aged 12-21 years, the ROC curve was optimized at a slightly higher hemoglobin threshold of ,13.0 g/dL with a sensitivity of 63.5% (95% CI 5 58.9%, 68.1%) and a specificity of 71.3% (95% CI 5 69.5%, 73.0%). For non-Black women, the ROC curve was also optimized at a slightly higher hemoglobin threshold of ,13.1 g/dL with a sensitivity of 65.3% (95% CI 5 61.6%, 68.9%) and a specificity of 77.5% (95% CI 5 76.2%, 78.7%).
DISCUSSION
The ROC curves generated in this analysis of 2003-2010 NHANES data confirm that the current hemoglobin thresholds for an abnormal or anemic value have poor sensitivity for ID. The optimal hemoglobin threshold to prompt further iron testing has not been considered. Although hemoglobin testing in clinical medicine has a scope beyond detection of ID, it is frequently used for this purpose in the context of preventive care. The study results suggest that redefining abnormal to ,12.8 g/dL is a more appropriate threshold when screening reproductive-age women for ID. If age and race are considered, the optimal threshold changes slightly as ,12.7 g/dL for older women, ,12.5 g/dL for Black women, and ,13.0 g/dL for non-Black women. Similar results were obtained when ID was defined by a ferritin ,12 mg/L.
Anemia is defined as a value less than the fifth percentile of the distribution of hemoglobin concentration in a healthy population based on age and sex. 1, 3 Prior publications using an older ID model (2 of 3 positive test results including low mean cell volume, high erythrocyte protoporphyrin, or low transferrin saturation) similarly demonstrate that current hemoglobin thresholds have low sensitivity (37%) for ID among reproductive-age women (specificity of 93%). 1 The impact of varying hemoglobin thresholds in various clinical situations has been debated in the literature on transfusion criteria for septic shock, premature infants, and morbidity in military combat. [30] [31] [32] Similarly, the pros and cons of changing the hemoglobin threshold to improve ID screening are also worth consideration.
Although the ROC curves for all reproductive-age women are optimized at a hemoglobin threshold of 12.8 g/dL, use of this new threshold will increase the number of women sent for additional laboratory studies to exclude ID. Undetected ID has been associated with negative effects on academic performance, mood, and concentration with improvements in symptoms after iron supplementation. [5] [6] [7] The long-term cost of a missed diagnosis of ID vs the increased cost of additional iron studies (ferritin and transferrin receptor) has not been examined. The probability of ID in women with a hemoglobin threshold of ,12.8 g/dL is 13.5% or 1 in 8. In contrast, approximately 30% of women with a hemoglobin threshold of ,12.0 g/dL will have ID. Thus, the optimal threshold may lie in between. Further steps may include a cost-effectiveness model varying the hemoglobin threshold.
Comparing younger and older women, the ROC curves were optimized at a hemoglobin threshold of 12.8 and 12.7 g/dL, respectively. Although this difference is unlikely to be clinically significant, it is notable that the AUC was significantly better for older compared with younger women. This is likely related to the higher prevalence of ID anemia among older women but comparatively lower prevalence of ID without anemia in this age group. Similarly, when Black and non-Black women are examined separately, the optimal hemoglobin threshold changes. The cost and clinical significance of this difference of 12.5 vs 13.0 g/dL will need to be considered.
Limitations. NHANES is intended to be representative of the US population; thus, the hemoglobin thresholds identified in this analysis should be applicable to the general US population. Several different models exist to define ID. The body iron model by Cook et al was adopted by the NHANES starting in 2003 to define the iron status of the US population. Before this, models using 2 of 3 abnormal iron-related laboratory values were used. 1, 3 However, in both cases, current hemoglobin thresholds consistently demonstrate poor sensitivity for detection of ID. It may be that changing the ID model results in slightly different hemoglobin thresholds than identified in this analysis. Hemoglobin concentration may also vary by altitude and smoking status, which were not factored into this analysis. 1 Altitude was not a part of the NHANES questionnaire. Subjective responses on exposure to tobacco products did not give a clear indication of the regularity and duration of tobacco use to factor into the analysis, specifically among younger participants. Blood conditions such as sickle cell anemia and thalassemia were also not able to be considered with the available data. In addition, although age and racial/ethnic variations in values for ferritin and transferrin receptors introduce a potential source of error, unlike hemoglobin, 15 we did not find standard published adjustments for the abnormal cut-points for these parameters by age and race, which could be readily incorporated into the analysis.
CONCLUSIONS
The study results confirm the poor sensitivity of current hemoglobin thresholds for identification of ID among reproductive-age women. Using a higher threshold when identification of ID is the goal (,12.8 g/dL) will improve the detection of ID in this population.
